Inventor · disambiguated record
Rudolph E. Tanzi
Also filed as: TANZI RUDOLPH · TANZI RUDOLPH E · TANZI RUDOLPH EMILE
31 granted patents·34 pending applications·414 citations·filing 1993–2023
97Inventor score
Files withGEN HOSPITAL CORP29MASSACHUSETTS GEN HOSPITAL10TANZI RUDOLPH E3MOIR ROBERT2NEUROGENETICS INC2
Top patents by PatentIndex Score
65 records- 0195US11679095B2Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Jun 20, 2023·3 cites·17 claims
- 0288US5891991AAmyloid precursor-like protein and uses thereofGEN HOSPITAL CORP·Filed 1996·Granted Apr 6, 1999·100 cites·5 claims
- 0387US10888600B2Methods and agents for treating Alzheimer's diseaseMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jan 12, 2021·3 cites·3 claims
- 0486US6323218B1Agents for use in the treatment of Alzheimer's diseaseGEN HOSPITAL CORP·Filed 1998·Granted Nov 27, 2001·64 cites·36 claims
- 0582US7955812B2Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomersGEN HOSPITAL CORP·Filed 2005·Granted Jun 7, 2011·5 cites·7 claims
- 0678US2024082207A1Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 0774US6447775B1Modulators of expression and function of LRP in Alzheimer's diseaseGEN HOSPITAL CORP·Filed 1999·Granted Sep 10, 2002·28 cites·7 claims
- 0873US7326540B2Methods for identifying compounds that modulate stabilization of secretase-associated proteinsGEN HOSPITAL CORP·Filed 2004·Granted Feb 5, 2008·4 cites·7 claims
- 0973US5972634ADiagnostic assay for Alzheimer's disease: assessment of Aβ abnormalitiesGEN HOSPITAL CORP·Filed 1994·Granted Oct 26, 1999·33 cites·30 claims
- 1072US9403815B2Compounds and uses thereof in modulating levels of various amyloid beta peptide alloformsWAGNER STEVEN L·Filed 2011·Granted Aug 2, 2016·4 cites·20 claims
- 1172US6472140B1α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.GEN HOSPITAL CORP·Filed 1999·Granted Oct 29, 2002·42 cites·24 claims
- 1271US7781177B2Measurement of GGA proteins for diagnosing BACE associated diseaseGEN HOSPITAL CORP·Filed 2007·Granted Aug 24, 2010·1 cites·19 claims
- 1369US9937231B2Methods and agents for treating Alzheimer's diseaseMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Apr 10, 2018·1 cites·18 claims
- 1465US9938263B2Gamma-secretase modulatorsTHE REGENTS OF THE UNIV OF CALIFORNIA A CALIFORNIA CORPORATION·Filed 2014·Granted Apr 10, 2018·1 cites·23 claims
- 1564US6156311AModulators of expression and function of LRP in alzheimer's diseaseAMERICAN NAT RED CROSS·Filed 1996·Granted Dec 5, 2000·26 cites·6 claims
- 1663US6365414B1Vitro system for determining formation of Aβ amyloidGEN HOSPITAL CORP·Filed 1994·Granted Apr 2, 2002·15 cites·4 claims
- 1761US11117884B2Potent gamma-secretase modulatorsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Sep 14, 2021·0 cites·14 claims
- 1861US6342350B1Alpha-2-macroglobulin diagnostic testGEN HOSPITAL CORP·Filed 1998·Granted Jan 29, 2002·26 cites·10 claims
- 1960US7618634B2Neurotoxic oligomersPRANA BIOTECHNOLOGY LTD·Filed 2001·Granted Nov 17, 2009·1 cites·6 claims
- 2060US6638711B1Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formationGEN HOSPITAL CORP·Filed 2000·Granted Oct 28, 2003·3 cites·9 claims
- 2160US2024148832A1Astrocyte Interleukin-3 Reprograms Microglia and Limits Alzheimer`s DiseaseMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 2258US2025325558A1Modulation of bace1 as a therapy for spinocerebellar ataxiaFOWLER ALAN JEROME·Filed 2023·Application pending·0 cites
- 2358US2010311726A1Reduction of beta-amyloid levels by treatment with the small molecule differentiation-inducing factorMYRE MICHAEL·Filed 2008·Application pending·0 cites
- 2457US2015218259A9Antibodies to cross-linked amyloid beta oligomersGEN HOSPITAL CORP·Filed 2014·Application pending·0 cites
- 2556US7045531B1Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelatorGEN HOSPITAL CORP·Filed 1998·Granted May 16, 2006·19 cites·4 claims
- 2656US5643726AMethods for modulating transcription from the amyloid β-protein precursor (APP) promoterGEN HOSPITAL CORP·Filed 1994·Granted Jul 1, 1997·15 cites·18 claims
- 2755US2006074104A1Use of clioquinol for the therapy of alzheimer's diseaseBUSH ASHLEY I·Filed 2005·Application pending·0 cites
- 2855US2019240194A1Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 2955US2010113570A1Prevention and treatment of post-operative cognitive dysfunctionGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 3053US2024174608A1Compounds for brain imagingMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 3152US2005170437A1Methods and compositions relating to modulating amyloid precursor protein cleavageGEN HOSPITAL CORP·Filed 2004·Application pending·0 cites
- 3251US2022218652A1Methods of treating cytokine release syndromeMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 3350US2002025944A1Use of clioquinol for the therapy of Alzheimer's diseaseFiled 2001·Application pending·0 cites
- 3450US2002028462A1Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's diseaseGEN HOSPITAL CORP·Filed 2001·Application pending·0 cites
- 3550US2013022994A1Regulation of bace degradationGEN HOSPITAL CORP·Filed 2012·Application pending·0 cites
- 3649US6248555B1Genetic alterations related to familial alzheimer's diseaseGEN HOSPITAL CORP·Filed 1996·Granted Jun 19, 2001·5 cites·52 claims
- 3749US2012114635A1Antibodies to cross-linked amyloid beta oligomersMOIR ROBERT·Filed 2011·Application pending·0 cites
- 3848US12458622B2Methods of treatment of coronavirus-induced inflammation conditionsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Nov 4, 2025·0 cites·25 claims
- 3948US2004067512A1Single nucleotide polymorphisms and mutations on Alpha-2-MacroglobulinNEUROGENETICS INC·Filed 2003·Application pending·0 cites
- 4048US2005118226A1Methods for treating ACAT-related diseasesFiled 2004·Application pending·0 cites
- 4147US2002115223A1In vitro system for determining formation of abeta amyloidGEN HOSPITAL CORP·Filed 2002·Application pending·0 cites
- 4246US2003162202A1Single nucleotide polymorphisms and mutations on Alpha-2-MacroglobulinFiled 2002·Application pending·0 cites
- 4346US2005009031A1Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseasesFiled 2003·Application pending·0 cites
- 4445US2003170678A1Genetic markers for Alzheimer's disease and methods using the sameNEUROGENETICS INC·Filed 2002·Application pending·0 cites
- 4545US2003224380A1Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseasesGEN HOSPITAL CORP·Filed 2002·Application pending·0 cites
- 4644US2011200564A1Diagnosis and treatment of alzheimer's disease (ad)TANZI RUDOLPH·Filed 2010·Application pending·0 cites
- 4744US2003180880A1Chromosome 1 gene and gene products related to alzheimer's diseaseUNIV WASHINGTON·Filed 2002·Application pending·0 cites
- 4844US2005112543A1Method of screening for drugs useful in treating Alzheimer's diseaseGEN HOSPITAL CORP·Filed 2003·Application pending·0 cites
- 4944US2020121666A1Tau phosphorylation inhibitors and methods for treating or preventing alzheimer's diseaseTHE METHODIST HOSPITAL SYSTEM·Filed 2018·Application pending·0 cites
- 5044US2002082273A1Agents for use in the treatment of alzheimer's diseaseFiled 2001·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rudolph E. Tanzi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →